Provided by Tiger Fintech (Singapore) Pte. Ltd.

Annexon, Inc.

2.25
+0.01000.45%
Post-market: 2.250.00000.00%19:44 EDT
Volume:1.10M
Turnover:2.50M
Market Cap:246.85M
PE:-2.24
High:2.31
Open:2.24
Low:2.22
Close:2.24
Loading ...

Annexon Biosciences Reports Q3 Financial Results

TIPRANKS
·
15 Nov 2024

Annexon Biosciences: Buy Rating Backed by Promising Data Releases and Strategic Long-term Potential

TIPRANKS
·
15 Nov 2024

Annexon Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024

Annexon Q3 EPS $(0.25) Beats $(0.31) Estimate

Benzinga
·
14 Nov 2024

Annexon reports Q3 EPS (25c), consensus (27c)

TIPRANKS
·
14 Nov 2024

Annexon: Topline Data Expected Second Half 2026

THOMSON REUTERS
·
14 Nov 2024

Annexon: Anticipated Runway Into Second Half 2026

THOMSON REUTERS
·
14 Nov 2024

Annexon Biosciences Q3 Cash & Investments USD 340.1 Million

THOMSON REUTERS
·
14 Nov 2024

Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones

GlobeNewswire
·
14 Nov 2024

Annexon Biosciences to Present at the Jefferies London Healthcare Conference

GlobeNewswire
·
14 Nov 2024

Annexon presents Phase 2 Vision Preservation data with ANX007 in dry AMD

TIPRANKS
·
22 Oct 2024

Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting

GlobeNewswire
·
22 Oct 2024

We're Hopeful That Annexon (NASDAQ:ANNX) Will Use Its Cash Wisely

Simply Wall St.
·
21 Oct 2024

Annexon reports inducement grants under Nasdaq listing rule

TIPRANKS
·
16 Oct 2024

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
16 Oct 2024

Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting

GlobeNewswire
·
15 Oct 2024